Top

Published in:

01-04-2022 | Fluorescence in Situ Hybridization | Original Article

NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion

Authors: Min Chen, Sha Zhao, Zuoyu Liang, Weiya Wang, Ping Zhou, Lili Jiang

Published in: Virchows Archiv | Issue 4/2022

Abstract

Nuclear protein in testis (NUT) carcinoma (NC) is a rare aggressive tumor with a typical NUTM1 gene rearrangement. Herein, we aimed to investigate the morphological and genetic features of head and neck NC. Immunohistochemistry staining for NUT (C52B1) was performed for 118 samples of head and neck poorly differentiated/undifferentiated carcinoma. Diffuse NUT staining was further confirmed via fluorescence in situ hybridization and next-generation sequencing. Two parotid gland NC cases, one in a 22-year-old man and one in a 52-year-old woman, were confirmed (2/118, 1.6%). Typical morphological features, including squamous cells and abrupt keratinization, were observed. Diffuse pankeratin, CK5/6, p63, and MYC expression were noted, while CD34, CD99, synaptophysin, chromogranin A, TTF1, S-100, and PD-L1 staining and EBER in situ hybridization (EBV-ISH) were negative. Both tumors harbored a NUTM1 rearrangement: a classic BRD4-NUTM1 fusion and a rare ZNF532-NUTM1 fusion. Furthermore, trisomy 8 and three copies of the MYC gene were detected in both cases. Next-generation sequencing revealed six additional somatic alterations, a low tumor mutation burden, and microsatellite stability. Patient 1 died from the disease after 15 months, and patient 2 was alive after 8 months. Parotid gland NC exhibits diverse morphological features and heterogeneous genotypes. To the best of our knowledge, this is the first report of parotid gland NC with a ZNF532-NUTM1 fusion.

Kubonishi I, Takehara N, Iwata J, Sonobe H, Ohtsuki Y, Abe T, Miyoshi I (1991) Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res 51(12):3327–3328PubMed

Kees UR, Mulcahy MT, Willoughby ML (1991) Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am J Pediatr Hematol Oncol 13(4):459–464. https://doi.org/10.1097/00043426-199124000-00011CrossRefPubMed

French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA (2003) BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 63(2):304–307PubMed

French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, Nose V, Vargas SO, Moschovi M, Tzortzatou-Stathopoulou F, Miyoshi I, Perez-Atayde AR, Aster JC, Fletcher JA (2004) Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 22(20):4135–4139. https://doi.org/10.1200/JCO.2004.02.107CrossRefPubMed

Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA (2012) Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 18(20):5773–5779. https://doi.org/10.1158/1078-0432.CCR-12-1153CrossRefPubMedPubMedCentral

Giridhar P, Mallick S, Kashyap L, Rath GK (2018) Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases. Eur Arch Otorhinolaryngol 275(3):815–821. https://doi.org/10.1007/s00405-018-4882-yCrossRefPubMed

Chau NG, Ma C, Danga K, Al-Sayegh H, Nardi V, Barrette R, Lathan CS, DuBois SG, Haddad RI, Shapiro GI, Sallan SE, Dhar A, Nelson JJ, French CA (2019) An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 Patients. JNCI Cancer Spectr 4(2):pkz094. https://doi.org/10.1093/jncics/pkz094CrossRefPubMedPubMedCentral

Alekseyenko AA, Walsh EM, Zee BM, Pakozdi T, Hsi P, Lemieux ME, Dal Cin P, Ince TA, Kharchenko PV, Kuroda MI, French CA (2017) Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci USA 114(21):E4184–E4192. https://doi.org/10.1073/pnas.1702086114CrossRefPubMedPubMedCentral

Shiota H, Elya JE, Alekseyenko AA, Chou PM, Gorman SA, Barbash O, Becht K, Danga K, Kuroda MI, Nardi V, French CA (2018) “Z4” complex member fusions in NUT carcinoma: implications for a novel oncogenic mechanism. Mol Cancer Res 16(12):1826–1833. https://doi.org/10.1158/1541-7786.MCR-18-0474CrossRefPubMedPubMedCentral

10.

McEvoy CR, Fox SB, Prall OWJ (2020) Emerging entities in NUTM1-rearranged neoplasms. Genes Chromosomes Cancer 59(6):375–385. https://doi.org/10.1002/gcc.22838CrossRefPubMed

11.

Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM (2012) Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Am J Surg Pathol 36(8):1222–1227. https://doi.org/10.1097/PAS.0b013e318258f03bCrossRefPubMedPubMedCentral

12.

den Bakker MA, Beverloo BH, van den Heuvel-Eibrink MM, Meeuwis CA, Tan LM, Johnson LA, French CA, van Leenders GJ (2009) NUT midline carcinoma of the parotid gland with mesenchymal differentiation. Am J Surg Pathol 33(8):1253–1258. https://doi.org/10.1097/PAS.0b013e3181abe120CrossRef

13.

Park HS, Bae YS, Yoon SO, Lim BJ, Hong HJ, Ro JY, Hong SW (2014) Usefulness of nuclear protein in testis (NUT) immunohistochemistry in the cytodiagnosis of NUT midline carcinoma: a brief case report. Korean J Pathol 48(4):335–338. https://doi.org/10.4132/KoreanJPathol.2014.48.4.335CrossRefPubMedPubMedCentral

14.

Klijanienko J, Le Tourneau C, Rodriguez J, Caly M, Theocharis S (2016) Cytological features of NUT midline carcinoma arising in sino-nasal tract and parotid gland: report of two new cases and review of the literature. Diagn Cytopathol 44(9):753–756. https://doi.org/10.1002/dc.23506CrossRefPubMed

15.

Vulsteke C, Lurquin E, Debiec-Rychter M, Gheysens O, Nuyts S, Schoenaers J, Politis C, Mebis J, Hauben E, Clement PM (2016) First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation. J Chemother 28(3):242–246. https://doi.org/10.1179/1973947815Y.0000000046CrossRefPubMed

16.

Lemelle L, Pierron G, Fréneaux P, Huybrechts S, Spiegel A, Plantaz D, Julieron M, Dumoucel S, Italiano A, Millot F, Le Tourneau C, Leverger G, Chastagner P, Carton M, Orbach D (2017) NUT carcinoma in children and adults: a multicenter retrospective study. Pediatr Blood Cancer 64(12). https://doi.org/10.1002/pbc.26693

17.

Storck S, Kennedy AL, Marcus KJ, Teot L, Vaughn J, Gnekow AK, Märkl B, Leuschner I, DuBois SG, French CA, Frühwald MC (2017) Pediatric NUT-midline carcinoma: therapeutic success employing a sarcoma based multimodal approach. Pediatr Hematol Oncol 34(4):231–237. https://doi.org/10.1080/08880018.2017.1363839CrossRefPubMed

18.

Agaimy A, Fonseca I, Martins C, Thway K, Barrette R, Harrington KJ, Hartmann A, French CA, Fisher C (2018) NUT carcinoma of the salivary glands: clinicopathologic and molecular analysis of 3 cases and a survey of NUT expression in salivary gland carcinomas. Am J Surg Pathol 42(7):877–884. https://doi.org/10.1097/PAS.0000000000001046CrossRefPubMedPubMedCentral

19.

Esteves G, Ferreira J, Afonso R, Martins C, Zagalo C, Félix A (2020) HDAC overexpression in a NUT midline carcinoma of the parotid gland with exceptional survival: a case report. Head Neck Pathol 14(4):1117–1122. https://doi.org/10.1007/s12105-020-01130-6CrossRefPubMedPubMedCentral

20.

Saik WN, Da Forno P, Thway K, Khurram SA (2021) NUT carcinoma arising from the parotid gland: a case report and review of the literature. Head Neck Pathol 15(3):1064–1068. https://doi.org/10.1007/s12105-020-01254-9CrossRefPubMed

21.

Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, Hong SM, Schwartz BE, Cameron MJ, Rubin MA, Chang MC, Aster JC, French CA (2009) Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 33(7):984–991. https://doi.org/10.1097/PAS.0b013e318198d666

22.

Jung M, Kim S, Lee JK, Yoon SO, Park HS, Hong SW, Park WS, Kim JE, Kim J, Keam B, Kim HJ, Kang HJ, Kim DW, Jung KC, Kim YT, Heo DS, Kim TM, Jeon YK (2019) Clinicopathological and preclinical findings of NUT carcinoma: a multicenter study. Oncologist 24(8):e740–e748. https://doi.org/10.1634/theoncologist.2018-0477

23.

Chen M, Yang J, Lv L, Li Y, Tang Y, Liu W, Wang W, Jiang L (2021) Comprehensive genetic profiling of six pulmonary nuclear protein in testis carcinomas with a novel micropapillary histological subtype in two cases. Hum Pathol 115:56–66. https://doi.org/10.1016/j.humpath.2021.02.004CrossRefPubMed

24.

Lee T, Cho J, Baek CH, Son YI, Jeong HS, Chung MK, Hong SD, Ahn YC, Oh DR, Noh JM, Park K, Ahn MJ, Kim HJ, Kim YK, Ko YH (2020) Prevalence of NUT carcinoma in head and neck: analysis of 362 cases with literature review. Head Neck 42(5):924–938. https://doi.org/10.1002/hed.26067CrossRefPubMed

25.

Seethala RR, Stenman G (2017) Update from the 4th edition of the World Health Organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol 11(1):55–67. https://doi.org/10.1007/s12105-017-0795-0CrossRefPubMedPubMedCentral

26.

Hung YP, Chen AL, Taylor MS, Huynh TG, Kem M, Selig MK, Nielsen GP, Lennerz JK, Azzoli CG, Dagogo-Jack I, Kradin RL, Mino-Kenudson M (2021) Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor-1 and neuroendocrine markers. Histopathology 78(6):896–904. https://doi.org/10.1111/his.14306CrossRefPubMed

27.

Pezzuto F, Fortarezza F, Mammana M, Pasello G, Pelosi G, Rea F, Calabrese F (2020) Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfall. Histopathology 77(3):508–510. https://doi.org/10.1111/his.14166CrossRefPubMed

28.

Grayson AR, Walsh EM, Cameron MJ, Godec J, Ashworth T, Ambrose JM, Aserlind AB, Wang H, Evan G, Kluk MJ, Bradner JE, Aster JC, French CA (2014) MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene 33(13):1736–1742. https://doi.org/10.1038/onc.2013.126CrossRefPubMed

29.

Chien YW, Hsieh TH, Chu PY, Hsieh SM, Liu ML, Lee JC, Liu YR, Ku JW, Kao YC (2019) Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family. Genes Chromosomes Cancer 58(11):809–814. https://doi.org/10.1002/gcc.22785CrossRefPubMed

30.

Agaimy A, Haller F, Renner A, Niedermeyer J, Hartmann A, French CA (2021) misleading germ cell phenotype in pulmonary NUT carcinoma harboring the ZNF532-NUTM1 fusion. Am J Surg Pathol. https://doi.org/10.1097/PAS.0000000000001774CrossRefPubMedPubMedCentral

Title: NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion
Authors: Min Chen
Sha Zhao
Zuoyu Liang
Weiya Wang
Ping Zhou
Lili Jiang
Publication date: 01-04-2022
Publisher: Springer Berlin Heidelberg
Keyword: Fluorescence in Situ Hybridization
Published in: Virchows Archiv / Issue 4/2022
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-021-03253-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2022

Epithelioid leiomyosarcoma of broad ligament harboring PGR-NR4A3 and UBR5-PGR gene fusions: a unique case report

Myxoid type and non-myxoid type of intimal sarcoma in large vessels and heart: review of histological and genetic profiles of 20 cases

Gene expression profiling using targeted RNA-sequencing to elucidate the progression from histologically normal lung tissues to non-invasive lesions in invasive lung adenocarcinoma

The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study

Distinctive patterns of marrow involvement by classic Hodgkin lymphoma are clues for diagnosis and subtyping

Desmoplastic reactions and epithelial-mesenchymal transition proteins in stages II and III colorectal cancer: association with and prognostic value for disease-free survival